No headlines found.
No press releases found.
No news found.
Revelation Biosciences - Warrant trades on the stock market under the symbol REVBW.
As of September 9, 2026, REVBW stock price was flat at $0.01 with million shares trading.
REVBW has a beta of 1.76, meaning it tends to be more sensitive to market movements. REVBW has a correlation of 0.02 to the broad based SPY ETF.
REVBW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, REVBW traded as high as $.04 and as low as $.00.
REVBW has underperformed the market in the last year with a price return of -32.9% while the SPY ETF gained +18.8%. REVBW has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -5.1% and -5.1%, respectively, while the SPY returned +3.5% and -0.4%, respectively.
REVBW support price is $.01 and resistance is $.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that REVBW shares will trade within this expected range on the day.
